COVID-۱۹ Pandemic and Neurological Disease: A Critical Review of the Existing Literature
- سال انتشار: 1399
- محل انتشار: مجله اقدامات و تحقیقات بیمارستانی، دوره: 5، شماره: 3
- کد COI اختصاصی: JR_HPR-5-3_001
- زبان مقاله: انگلیسی
- تعداد مشاهده: 179
نویسندگان
Department of Family Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA ۹۰۰۵۹, USA
چکیده
Most of what we know about the coronavirus disease ۲۰۱۹ (COVID-۱۹) is limited to the severe acute respiratory syndrome, epidemiology, fatality, and acute care. However, infection with COVID-۱۹ may also involve the central nervous system (CNS), which may or may not be due to a multi-organ injury. Our aim in this paper is to briefly summarize the main aspects of the growing literature on neurological manifestations of the COVID-۱۹ infection. As such, after mentioned some general background on the economic and medical pandemic on the populations, the healthcare system, and the society, we summarize some common aspects of the published literature on neurological manifestations of the COVID-۱۹ infection. We also highlight the existing gaps in the literature, which requires additional work. The most common neurological manifestation of COVID-۱۹ infection is the olfactory deficit. However, it is still unknown if it is inflammatory or degenerative in nature. Still, the incidence of neurological involvement, and also mechanisms and their treatments are unknown. This literature is predominantly composed of opinions and reviews rather than original articles, so the patients’ data are not used for a majority of the studies. Multi-center studies that not only conduct chest CT or MRI but also brain CT or MRI are needed. Randomized trials are still required on the management of acute and chronic neurological conditions due to COVID-۱۹ infection. Cohort studies may also determine the natural history of the conditions and factors that are prognostic. Furthermore, while disparities in COVID-۱۹ infections are known, inequalities in neurological manifestations are unknown. Besides, the efficacy of specific treatments on CNS involvement is still unknown. We will discuss the health care needs of patients with chronic neurological conditions. We end the paper with a few recommendations for practice and research.کلیدواژه ها
Coronavirus disease ۲۰۱۹ (COVID-۱۹), Severe Acute Respiratory Syndrome Coronavirus ۲ (SARS-CoV-۲), neurology, Neurological disease, brain, Central nervous system (CNS)اطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.